Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
AssigneeInsmed Incorporated
InventorJeff Weers
Life of this patent
Estimating the term…
Abstract
A system for treating or providing prophylaxus against a pulmonary infection is disclosed comprising: a) a pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition, and b) an inhalation delivery device. A method for providing prophylaxis against a pulmonary infection in a patient and a method of reducing the loss of antiinfective encapsulated in a lipid-based composition upon nebulization comprising administering an aerosolized pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition is also disclosed.
Claims30
A method for treating a pulmonary infection due to Pseudomonas aeruginosa in a patient in need thereof, comprising,
- aerosolizing a pharmaceutical formulation comprising a mixture of free fluoroquinolone antibiotic agent, an aqueous dispersion of fluoroquinolone antibiotic agent encapsulated in a plurality of liposomes, and a pharmaceutical excipient, via a nebulizer, to form an aerosolized pharmaceutical formulation, wherein the lipid component of the plurality of liposomes consists of a phosphatidylcholine and cholesterol, and wherein prior to aerosolizing the pharmaceutical formulation, the ratio by weight of the free fluoroquinolone antibiotic agent to the encapsulated fluoroquinolone antibiotic agent in the pharmaceutical formulation is between about 1:10 and about 10:1, and
- administering the aerosolized pharmaceutical formulation to the lungs of the patient,
- wherein the ratio by weight of the free fluoroquinolone antibiotic agent to the encapsulated fluoroquinolone antibiotic agent in the aerosolized pharmaceutical formulation is between about 1:10 and about 10:1.
Dependencies are inferred from the claim text.